wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26747776-27DE50B3-F4C7-48CB-9C10-3A0ED96875D5
Q26747776-27DE50B3-F4C7-48CB-9C10-3A0ED96875D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747776-27DE50B3-F4C7-48CB-9C10-3A0ED96875D5
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
P2860
Q26747776-27DE50B3-F4C7-48CB-9C10-3A0ED96875D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747776-27DE50B3-F4C7-48CB-9C10-3A0ED96875D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7542c0db456bc31640fa566892a7b85cf165a4d
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.